Maybe you should learn how to read
On Friday 12 April 2024, the Cohort Review Committee cleared the fifth cohort in the IT arm of the monotherapy dose escalation portion of the MAST trial, with no safety signals seen to date.
Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-97
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.002(4.55%) |
Mkt cap ! $312.4M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.2¢ | $529.7K | 12.46M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 3781693 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 2787665 | 23 |
View Market Depth
| Last trade - 12.01pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |